Dengue Fever

🩺What is Dengue Fever?

The WHO 2009 dengue classification replaced the previous 1997 WHO classification (dengue fever, dengue hemorrhagic fever, dengue shock syndrome). The new classification is simpler and more clinically relevant. Dengue is defined as fever plus ≥2 of: nausea/vomiting, rash, aches/pains, positive tourniquet test, leukopenia, or any warning sign. Warning signs include: abdominal pain/tenderness, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy/restlessness, liver enlargement >2cm, increasing hematocrit with decreasing platelets. Severe dengue involves severe plasma leakage leading to shock or respiratory distress, severe bleeding, or severe organ impairment (liver AST/ALT ≥1000, impaired consciousness, heart or other organ failure).

🏥Signs & Symptoms

The following clinical signs and symptoms are commonly assessed when evaluating Dengue Fever:

• Fever and Dengue Symptoms
• Abdominal Pain or Tenderness
• Persistent Vomiting (≥3 times/day)
• Clinical Fluid Accumulation (pleural effusion, ascites)
• Mucosal Bleeding
• Lethargy or Restlessness
• Liver Enlargement > 2 cm
• Increase in Hematocrit concurrent with rapid decrease in platelet count
• Severe Plasma Leakage leading to shock or respiratory distress
• Severe Bleeding evaluated by clinician
• Severe Organ Impairment (AST/ALT ≥1000, impaired consciousness, heart failure)

🔬Causes & Etiology

The WHO 2009 dengue classification replaced the previous 1997 WHO classification (dengue fever, dengue hemorrhagic fever, dengue shock syndrome). The new classification is simpler and more clinically relevant. Dengue is defined as fever plus ≥2 of: nausea/vomiting, rash, aches/pains, positive tourniquet test, leukopenia, or any warning sign. Warning signs include: abdominal pain/tenderness, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy/restlessness, liver enlargement >2cm, increasing hematocrit with decreasing platelets. Severe dengue involves severe plasma leakage leading to shock or respiratory distress, severe bleeding, or severe organ impairment (liver AST/ALT ≥1000, impaired consciousness, heart or other organ failure).

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Dengue Fever:

• WHO Dengue Severity Classification

  The WHO 2009 dengue classification categorizes patients into three severity groups: dengue without warning signs, dengue with warning signs (requiring close monitoring), and severe dengue (life-threatening).

🧬Diagnostic Logic & Scoring Breakdown

Dengue without warning signs: fever and ≥2 symptoms, no warning signs. Dengue with warning signs: fever + warning signs (≥1). Severe dengue: severe plasma leakage (shock, respiratory distress), severe bleeding, or severe organ involvement.

📢Clinical Significance & Implications

Dengue is the fastest-spreading mosquito-borne viral disease, with 390 million infections annually and 96 million clinically apparent cases. Early classification using WHO criteria guides appropriate management and reduces mortality from >20% to <1% with proper fluid management.

🛡️Prevention & Management

Evidence-based prevention and management strategies for Dengue Fever include:

• Adequate oral fluids, acetaminophen for fever (avoid NSAIDs), monitor for warning signs.
• Hospitalize, monitor vitals/hematocrit/platelets, IV fluids if needed, watch for severe dengue.
• The critical phase occurs around defervescence (day 3-7 of illness) when plasma leakage is maximal. Close monitoring during this period is essential for early detection of warning signs and prevention of severe dengue.

⚡Complications & Prognosis

Without proper management, Dengue Fever may lead to the following complications:

Dengue is the fastest-spreading mosquito-borne viral disease, with 390 million infections annually and 96 million clinically apparent cases. Early classification using WHO criteria guides appropriate management and reduces mortality from >20% to <1% with proper fluid management.

💡 Clinical Assessment Scenario Example

A child with fever for 3 days, abdominal pain, vomiting, and petechiae. No bleeding, no shock. Classification: Dengue with warning signs (abdominal pain + vomiting + mucosal bleeding).

💊Common Medications & Interventions

The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Dengue Fever:

⚠️Clinical Assessment Pitfalls

• ❌ Mistake: Using NSAIDs for fever or pain in suspected dengue.

  ✅ Correction: Acetaminophen (paracetamol) is the recommended antipyretic. NSAIDs increase bleeding risk.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Dengue Fever; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

❓Frequently Asked Questions

📚Evidence-Based References